Ronald J. Hinklin
Pfizer (United States)(US)
Publications by Year
Research Areas
Protein Tyrosine Phosphatases, RNA modifications and cancer, Biochemical and Molecular Research, ATP Synthase and ATPases Research, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer(2020)572 cited
- → Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity(2018)106 cited
- → Stereoselective N-Glycosylation by Staudinger Ligation(2004)88 cited
- → SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy(2023)65 cited
- → A Selective Estrogen Receptor Modulator Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats(2005)50 cited
- → Glycosyl Sulfonylcarbamates: New Glycosyl Donors with Tunable Reactivity(2001)47 cited
- → A Selective Estrogen Receptor Modulator for the Treatment of Hot Flushes(2006)36 cited
- → Identification of a New Class of Glucokinase Activators through Structure-Based Design(2013)32 cited
- → p-Methoxybenzyl Ether Cleavage by Polymer-Supported Sulfonamides(2002)27 cited
- → 5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved Properties(2016)23 cited